The attached picture is a copy of the BTA’s formal response to the NHS England Consultation “Items which should not routinely be prescribed in primary care: Consultation on guidance for CCGs”. It was sent to the ITT CAMPAIGN in response to their FOI request for a copy of the official response.
The highlight is they say patients on Liothyronine should not have it removed abruptly and it should be provided on basis of Clinical need. It also mentions the NHS reasons for switching due to cost is not acceptable and they should ultimately get their act together and find cheaper alternative sources.
A huge step forward I hope everyone agrees!
Personally think it’s following the onslaught of comments the BTF got in the last week on their Facebook page (thanks again to those who commented after I was blocked incidentally).
Hopefully something the NHS will now take very seriously!
[ Edited by admin to add these links:
The BTA document itself:
See also their document for endos: